Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non-infectious Uveitis Affecting the Posterior Segment of the Eye”

11 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 11 of 11 results

Post-approval studies (Phase 4)Study completedNCT00543296
What this trial is testing

Re-implantation of a Fluocinolone Acetonide Implant for Non-infectious Uveitis Affecting the Posterior Segment

Who this might be right for
Uveitis
Duke University 21
Large-scale testing (Phase 3)Study completedNCT01694186
What this trial is testing

Safety and Efficacy of an Injectable Fluocinolone Acetonide Intravitreal Insert

Who this might be right for
Non-Infectious Uveitis
EyePoint Pharmaceuticals, Inc. 129
Large-scale testing (Phase 3)Looking for participantsNCT05486468
What this trial is testing

The Use of Two YUTIQ Versus Sham for Treatment of Chronic Non Infectious Intraocular Inflammation Affecting the Posterior Segment

Who this might be right for
UveitisUveitis, PosteriorUveitis, Anterior+1 more
Texas Retina Associates 30
Not applicableEnded earlyNCT02951975
What this trial is testing

Ozurdex® in Patients With Non-infectious Uveitis Affecting the Posterior Segment of the Eye

Who this might be right for
Non-infectious Uveitis
Allergan 246
Large-scale testing (Phase 3)Ended earlyNCT05070728
What this trial is testing

Safety and Efficacy of an Injectable Fluocinolone Acetonide Intravitreal (FAI) Insert

Who this might be right for
UveitisUveitis, PosteriorUveitis, Intermediate
EyePoint Pharmaceuticals, Inc. 12
Large-scale testing (Phase 3)Study completedNCT02748512
What this trial is testing

Utilization and Safety of the Mk II Inserter and the Safety of the FAI Insert in Non-Infectious Uveitis

Who this might be right for
Non-Infectious Uveitis
EyePoint Pharmaceuticals, Inc. 26
Large-scale testing (Phase 3)Ended earlyNCT00456482
What this trial is testing

Safety and Efficacy of Fluocinolone Acetonide Intravitreal Implant

Who this might be right for
Non-infectious Uveitis
Bausch & Lomb Incorporated 239
Large-scale testing (Phase 3)Study completedNCT00407082
What this trial is testing

Safety and Efficacy of Fluocinolone Acetonide Intravitreal Implants

Who this might be right for
Noninfectious Posterior Uveitis
Bausch & Lomb Incorporated 278
Large-scale testing (Phase 3)Study completedNCT02746991
What this trial is testing

Safety and Efficacy Study of a FAI Insert in Subjects With Chronic Non-infectious Posterior Uveitis

Who this might be right for
Posterior UveitisIntermediate UveitisPanuveitis
EyePoint Pharmaceuticals, Inc. 153
Post-approval studies (Phase 4)Looking for participantsNCT06539481
What this trial is testing

Open Label Trial Studying the Safety and Effectiveness of ILUVIEN® (190μg) in Children and Adolescents, Who Have Recurrent Non-infectious Uveitis Affecting the Posterior Segment of the Eye.

Who this might be right for
Non-infectious Uveitis Affecting the Posterior Segment of the Eye
Alimera Sciences 25
Large-scale testing (Phase 3)Study completedNCT00468871
What this trial is testing

Safety and Efficacy of Fluocinolone Acetonide Intravitreal Implant vs Standardized Therapy

Who this might be right for
Non-infectious Uveitis
Bausch & Lomb Incorporated 140